APA (7th ed.) Citation

V, O., A, A., M, E., N, M., A, F., L, M., . . . S, R. (2022). Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease. American journal of hematology, 97(6), 731. https://doi.org/10.1002/ajh.26519

Chicago Style (17th ed.) Citation

V, Ortiz-Maldonado, et al. "Results of ARI-0001 CART19 Cell Therapy in Patients with Relapsed/refractory CD19-positive Acute Lymphoblastic Leukemia with Isolated Extramedullary Disease." American Journal of Hematology 97, no. 6 (2022): 731. https://doi.org/10.1002/ajh.26519.

MLA (9th ed.) Citation

V, Ortiz-Maldonado, et al. "Results of ARI-0001 CART19 Cell Therapy in Patients with Relapsed/refractory CD19-positive Acute Lymphoblastic Leukemia with Isolated Extramedullary Disease." American Journal of Hematology, vol. 97, no. 6, 2022, p. 731, https://doi.org/10.1002/ajh.26519.